Certain A Shares of Nanjing Vishee Medical Technology Co., Ltd are subject to a Lock-Up Agreement Ending on 21-JUL-2023. These A Shares will be under lockup for 1107 days starting from 9-JUL-2020 to 21-JUL-2023.

Details:
The company's controlling shareholders and the actual controllers Wang Zhiyu and the shareholder Nanjing Zhida Investment Management Consulting Center (Limited Partnership) committed that within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. If there is any case of dividends, bonus shares, capitalization of capital reserve and other similar cases, issue price will be adjusted according to ex-dividend and ex-interests.

The shareholder Nanjing Zhimingda Enterprise Management Consulting Center (Limited Partnership, Shenzhen Yanghe Biomedical Industrial Investment Co., Ltd., Directors and senior managers of Lian Qingming, Zhong Yiqun, Wu Xia, Xu Jinguo, Chen Lili, supervisor Hu Ping, Shi Yuling, Hanzhuo, shareholders Zhang Zhan, Su Cailong, Li Xiaoming, Shi Zhuangping, Tan Fei, Yang Chongxiang, Yang Yuqin, Zhou Dongyao, Zheng Guihua and core technical staff Huang He, Gao Fei, Qiu Kai, Liu Wenlong committed that within 12 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.